Evidence map›Paper›PMID 41471346›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Repurposing of FDA-Approved Antiviral Drugs Against Monkeypox Virus: Comparative In Vitro Screening and Structure Based In Silico Studies.

Yassmin Moatasim, Omnia Kutkat, Mokhtar Gomaa, Yaseen A M M Elshaier, Mina Nabil, Ahmed A El-Rashedy, Wael H Roshdy, Ghazi Kayali, Mohamed Ahmed Ali, Rabeh El-Shesheny

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yassmin MoatasimCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.ORCID 0000-0003-2159-2511
Omnia KutkatCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.
Mokhtar GomaaCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.
Yaseen A M M ElshaierDepartment of Organic and Medicinal Chemistry, Faculty of Pharmacy, University of Sadat City, Sadat City 32897, Egypt.
Mina NabilCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.
Ahmed A El-RashedyDepartment of Organic and Medicinal Chemistry, Faculty of Pharmacy, University of Sadat City, Sadat City 32897, Egypt.
Wael H RoshdyCentral Public Health Laboratory, Ministry of Health and Population, Cairo 11843, Egypt.ORCID 0000-0001-8412-3128
Ghazi KayaliHuman Link, Dubai P.O. Box 48800, United Arab Emirates.
Mohamed Ahmed AliCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.ORCID 0000-0002-5615-3212
Rabeh El-SheshenyCenter of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt.ORCID 0000-0002-8798-2240

Funding

National Research Centre MP130803
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antiviral screeningdrug repositioningin silicomolecular dockingMonkeypox

Identifiers

PMID41471346
PMCPMC12736150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.